Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > KR. S. BioSimilar TrastuzuMAb

---

KR. S. BioSimilar TrastuzuMAb's subsections
(*) EU Approval Date: 2017. 11.20
Company
TradeMark

KR. S. BioSimilar TrastuzuMAb's products
This section has no products